'Real-world' Australian experience of pomalidomide for relapsed and refractory myeloma.
| Title | 'Real-world' Australian experience of pomalidomide for relapsed and refractory myeloma. |
| Publication Type | Journal Article |
| Year of Publication | 2018 |
| Authors | Scott A, Weber N, Tiley C, Taylor K, Taper J, Harrison S, Chan K-L, Stark R, Lee C, Morris K, P Ho J, Dodds A, Ramanathan S, Ramakrishna R, Watson A-M, Auguston B, Kwok F, Quach H, Warburton P, Rowlings P, Mollee P |
| Journal | Leuk Lymphoma |
| Volume | 59 |
| Issue | 6 |
| Pagination | 1514-1516 |
| Date Published | 2018 06 |
| ISSN | 1029-2403 |
| Keywords | Antineoplastic Combined Chemotherapy Protocols, Australia, Drug Resistance, Neoplasm, Humans, Immunologic Factors, Multiple Myeloma, Recurrence, Retreatment, Thalidomide, Treatment Outcome |
| DOI | 10.1080/10428194.2017.1387911 |
| Alternate Journal | Leuk Lymphoma |
| PubMed ID | 29022836 |
